Paolo Tarantino, 2025 Yvonne’s “Top Voice” Award Winner, Research Fellow at Dana-Farber Cancer Institute, shared a post on X about a paper he co-authored with colleagues published in The Oncologist.
“SG is a highly effective ADCs, and when used adequately, it saves lives. This includes careful management of toxicities, with prophylaxis when indicated. In this article, we review the data and provide RW perspectives on the management of toxicities with SG.”
Katy Moore, Deputy Director of the Stephenson Cancer Center, shared this post, adding:
“This is a tremendous resource – gyn onc is just about to (hopefully) have SG in endometrial and none of us has really used it.”
Title: Clinical Perspective on Management of Key Adverse Events With Sacituzumab Govitecan
Authors: Sara M Tolaney, Guru P Sonpavde, Paolo Tarantino, Maryam B Lustberg, Hope S Rugo
You can read the Full Article in The Oncologist.
More posts featuring Paolo Tarantino on OncoDaily.